AVBP logo
AVBP NASDAQ US

ArriVent BioPharma, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jan 2024
$24.89
▲ +$0.67 (+2.77%)
Vol 363K
2
Quality Score
fail
Mkt Cap
$830.6M
ROE
-59.7%
D/E
0.00
Beta
1.10
52W
$15–$30

Wall Street Consensus

19 analysts · Apr 2026
7
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
94.7%
Buy Rating

Price Chart

Similar Stocks

TSHA
Taysha Gene Therapies Inc
$1.5B
NVAX
Novavax Inc
P/E 3.2
$1.1B
CRVS
Corvus Pharmaceuticals Inc
$575.1M
SVRA
Savara Inc
$1.2B
GERN
Geron Corp
$842.6M
KALV
Kalvista Pharmaceuticals Inc
$816.3M
CTMX
CytomX Therapeutics Inc
P/E 25.8
$721.8M
CMPX
Compass Therapeutics Inc.
$955.1M

Earnings

Beat rate: 25.0%
Next Report May 11, 2026
EPS Estimate: $-0.91
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.91 — —
Dec 2025 $-0.86 $-0.78 +$0.08
Sep 2025 $-0.81 $-0.83 $-0.02
Jun 2025 $-0.72 $-0.90 $-0.18

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -55.5% -55.5% -55.5% -55.5% -59.7% -59.7%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 12.74 12.74 12.74 12.74 14.90 14.90

Key Ratios

ROA (TTM)
-55.7%
P/B
3.5
EPS (TTM)
$-4.24
52W High
$29.71
52W Low
$15.47
$15.47 52-Week Range $29.71

How does AVBP compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

AVBP AAPG ABEO ABOS ABP

AVBP valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.5
▲ 42% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

AVBP profitability vs Biotechnology peers

ROE
-59.7%
▲ 11% above peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-55.7%
▼ 19% below peers (-46.7%)
vs Peers
vs Industry
Below avg

AVBP financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
14.9
▲ 236% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.1
▲ 14% above peers (1.0)
vs Peers
vs Industry
Less volatile

AVBP fundamentals radar

AVBP Peer median Industry

AVBP profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

AVBP vs peers: key metrics

Latest News

No related news yet